Patent · US Active

Cancer diagnosis based on levels of antibodies against Globo H and its fragments

US8158367B2 · kind B2 · utility

2Cited by
0References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 16, 2009
Grant dateApr 17, 2012
Priority date
Expiry dateAug 15, 2029

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/57415
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A cancer diagnostic method using a glycan array that contains Gb5 and Globo H, Bb2, Bb3, and/or Bb4.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.